Materiały źródłowe

• #1 Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

  During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] There’s no single test to specifically diagnose polycystic ovary syndrome (PCOS). Your health care provider is likely to start with a discussion of your symptoms, medications and any other medical conditions. Your provider also may ask about your menstrual periods and any weight changes. A physical exam includes checking for signs of excess hair growth, insulin resistance and acne. […] Blood tests can measure hormone levels. This testing can exclude possible causes of menstrual problems or androgen excess that mimic PCOS. […] An ultrasound can check the appearance of your ovaries and the thickness of the lining of your uterus. […] If you have a diagnosis of PCOS, your provider might recommend more tests for complications.

• #2 Diagnosing Polycystic Ovary Syndrome | NYU Langone Health

  https://nyulangone.org/conditions/polycystic-ovary-syndrome/diagnosis

  Polycystic ovary syndrome (PCOS) is a condition in which there is an imbalance in a womans hormones. […] To receive a diagnosis of PCOS, you must meet two of the following criteria: irregular ovulation, which is usually indicated by an irregular menstrual cycle or a lack of a cycle; signs of increased androgen levels or a blood test confirming you have increased levels; multiple small cysts on the ovaries. […] To diagnose PCOS, an endocrinologist, a doctor who specializes in hormonal disorders, conducts a physical exam. […] Your doctor may check your blood for levels of androgens, including testosterone, which tends to be higher in women with PCOS. […] Your doctor may also recommend a pelvic ultrasounda test that uses sound waves to create images of the uterus and the ovaries on a computer monitorto look for ovarian cysts.

• #3 Polycystic Ovarian Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK459251/

  Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder among females of reproductive age worldwide. […] PCOS is based on the presence of diagnostic criteria. […] This course explores the complexities surrounding PCOS, including the current diagnostic challenges and multifactorial pathophysiology, exploring the role of insulin resistance and hormonal abnormalities. […] Delayed diagnosis can contribute to complications, making timely lifestyle interventions crucial for symptom management and improving quality of life. […] Most society guidelines have accepted that PCOS may be diagnosed if 2 out of the 3 following clinical criteria are present: chronic oligo-anovulation, clinical or biological hyperandrogenism, and PCOM in the absence of any other pathology, which are part of the Rotterdam Criteria.

• #4 Diagnosis and management of polycystic ovarian syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10833093/

  Polycystic ovarian syndrome (PCOS) is a chronic disorder associated with infertility; miscarriage; adverse pregnancy outcomes; and cardiovascular, metabolic, psychological and neoplastic risks. […] Diagnosis of PCOS can be made based on the presence of any 2 of menstrual irregularities, clinical or biochemical hyperandrogenism or polycystic ovarian morphology on transvaginal ultrasonography. […] The Rotterdam criteria are the most widely accepted criteria for diagnosis of PCOS. Polycystic ovarian syndrome is diagnosed when 2 out of 3 of the following criteria are met and other diagnoses are excluded: Irregular cycles (if 3 yr post-menarche, 35 d apart or 21 d apart; 8 menstrual cycles per year; or 90 d for any 1 menstrual cycle), Clinical hyperandrogenism (acne, hirsutism, alopecia) or biochemical hyperandrogenism, Polycystic ovarian morphology on transvaginal ultrasonography or high antimullerian hormone.

• #5 Diagnosis and Treatment of Polycystic Ovary Syndrome | AAFP

  https://www.aafp.org/pubs/afp/issues/2016/0715/p106.html

  Polycystic ovary syndrome is the most common endocrinopathy among reproductive-aged women in the United States, affecting approximately 7% of female patients. […] Guidelines from the Endocrine Society recommend using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries, plus the exclusion of other diagnoses that could result in hyperandrogenism or ovulatory dysfunction. […] The Endocrine Society advises clinicians to diagnose PCOS using the 2003 Rotterdam criteria, although recommendations differ across guidelines. According to the Rotterdam criteria, diagnosis requires the presence of at least two of the following three findings: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries.

• #6 Polycystic Ovarian Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK459251/

  Newer criteria from the International Evidence-Based Guideline for the Assessment and Management of PCOS 2023 recommend that an adult diagnosis of PCOS requires the presence of 2 out of the following 3 criteria, as well as the exclusion of differential diagnoses with similar clinical features: Clinical or biochemical hyperandrogenism, Ovulatory dysfunction, Findings of polycystic ovaries on ultrasound or elevated AMH levels. […] When irregular menstrual cycles and hyperandrogenism are present, neither ultrasound nor AMH testing is necessary for the diagnosis of PCOS in adults. […] Excluding disorders that can mimic the clinical features of PCOS is also essential, including thyroid disease, hyperprolactinemia, and atypical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

• #7 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  The guideline provides 77 evidence-based and 54 consensus recommendations, with 123 practice points underpinned by a technical report on evidence synthesis and GRADE detailed considerations. […] Key recommendations and updates include that PCOS should be diagnosed using the 2018 International Evidence-based Guideline criteria, which built on the consensus based 2003 Rotterdam criteria. […] This requires the presence of two of the following: i) clinical / biochemical hyperandrogenism; ii) ovulatory dysfunction; and iii) polycystic ovaries on ultrasound; and here in 2023, alternatively anti-Mullerian hormone (AMH) can now be used instead of ultrasound, with the exclusion of other aetiologies. […] Importantly, where irregular menstrual cycles and hyperandrogenism are present, diagnosis is simplified and ultrasound or AMH are not required for diagnosis.

• #8 Polycystic Ovarian Syndrome: Practice Essentials, Background, Etiology

  https://emedicine.medscape.com/article/256806-overview

  In 2003, the European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) recommended that at least 2 of the following 3 features are required for PCOS to be diagnosed: Oligo-ovulation or anovulation manifested as oligomenorrhea or amenorrhea, Hyperandrogenism (clinical evidence of androgen excess) or hyperandrogenemia (biochemical evidence of androgen excess), Polycystic ovaries (as defined on ultrasonography). […] The Society of Obstetricians and Gynaecologists of Canada (SOGC) indicated that a diagnosis of polycystic ovarian syndrome (PCOS) is made in the presence of at least 2 of the following 3 criteria, when congenital adrenal hyperplasia, androgen-secreting tumors, or Cushing syndrome have been excluded: Oligo-ovulation or anovulation, Clinical/biochemical evidence of hyperandrogenism, Polycystic ovaries on ultrasonograms (12 small antral follicles in an ovary).

• #9 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  The guideline provides 77 evidence-based and 54 consensus recommendations, with 123 practice points underpinned by a technical report on evidence synthesis and GRADE detailed considerations. […] Key recommendations and updates include that PCOS should be diagnosed using the 2018 International Evidence-based Guideline criteria, which built on the consensus based 2003 Rotterdam criteria. […] This requires the presence of two of the following: i) clinical / biochemical hyperandrogenism; ii) ovulatory dysfunction; and iii) polycystic ovaries on ultrasound; and here in 2023, alternatively anti-Mullerian hormone (AMH) can now be used instead of ultrasound, with the exclusion of other aetiologies. […] Importantly, where irregular menstrual cycles and hyperandrogenism are present, diagnosis is simplified and ultrasound or AMH are not required for diagnosis.

• #10 Polycystic Ovary Syndrome: Assessment and Management Guidelines | AAFP

  https://www.aafp.org/pubs/afp/issues/2024/1100/practice-guidelines-polycystic-ovary-syndrome.html

  PCOS can be diagnosed without using ultrasonography in women with ovulatory dysfunction and clinical or biochemical evidence of hyperandrogenism. […] In adults, antimllerian hormone levels can be used instead of ultrasonography to indicate polycystic ovaries. […] To diagnose PCOS, two of the following criteria are required: clinical or biochemical evidence of hyperandrogenism, ovulatory dysfunction, ultrasound images showing polycystic ovaries or elevated antimllerian hormone levels. […] At least 60% of women with PCOS have evidence of hyperandrogenism using clinical or biochemical markers.

• #11 Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

  During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] There’s no single test to specifically diagnose polycystic ovary syndrome (PCOS). Your health care provider is likely to start with a discussion of your symptoms, medications and any other medical conditions. Your provider also may ask about your menstrual periods and any weight changes. A physical exam includes checking for signs of excess hair growth, insulin resistance and acne. […] Blood tests can measure hormone levels. This testing can exclude possible causes of menstrual problems or androgen excess that mimic PCOS. […] An ultrasound can check the appearance of your ovaries and the thickness of the lining of your uterus. […] If you have a diagnosis of PCOS, your provider might recommend more tests for complications.

• #12

  https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/diagnosis/

  See your GP if you have any typical symptoms of polycystic ovary syndrome (PCOS). […] Your GP will ask about your symptoms to help rule out other possible causes, and check your blood pressure. […] They’ll also arrange for you to have a number of hormone tests to find out whether the excess hormone production is caused by PCOS or another hormone-related condition. […] You may also need an ultrasound scan, which can show whether you have a high number of follicles in your ovaries (polycystic ovaries). […] A diagnosis of PCOS can usually be made if other rare causes of the same symptoms have been ruled out and you meet at least 2 of the following 3 criteria: you have irregular periods or infrequent periods this indicates that your ovaries do not regularly release eggs (ovulate) […] blood tests showing you have high levels of „male hormones”, such as testosterone (or sometimes just the signs of excess male hormones, even if the blood test is normal)

• #13 Diagnosis and management of polycystic ovarian syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10833093/

  Polycystic ovarian syndrome (PCOS) is a chronic disorder associated with infertility; miscarriage; adverse pregnancy outcomes; and cardiovascular, metabolic, psychological and neoplastic risks. […] Diagnosis of PCOS can be made based on the presence of any 2 of menstrual irregularities, clinical or biochemical hyperandrogenism or polycystic ovarian morphology on transvaginal ultrasonography. […] The Rotterdam criteria are the most widely accepted criteria for diagnosis of PCOS. Polycystic ovarian syndrome is diagnosed when 2 out of 3 of the following criteria are met and other diagnoses are excluded: Irregular cycles (if 3 yr post-menarche, 35 d apart or 21 d apart; 8 menstrual cycles per year; or 90 d for any 1 menstrual cycle), Clinical hyperandrogenism (acne, hirsutism, alopecia) or biochemical hyperandrogenism, Polycystic ovarian morphology on transvaginal ultrasonography or high antimullerian hormone.

• #14 Polycystic Ovary Syndrome: Making the Diagnosis – The ObG Project

  https://www.obgproject.com/2016/12/09/polycystic-ovary-syndrome-making-diagnosis/

  The Rotterdam Criteria requires two out of three of the following (after other causes are excluded): Clinical/biochemical signs of hyperandrogenism, Ovulatory dysfunction, Polycystic ovaries on ultrasound or elevated anti-mullerian hormone (AMH) levels. Note: If hyperandrogenism is present in the setting of irregular menses, ultrasound or AMH are not necessary. […] Consider PCOS when irregular menstrual cycles are present. Irregular Menses should be defined as follows: Normal if occurring in year 1 post menarche (considered part of pubertal transition), 1 to <3 years post menarche: <21 or >45 days, 3 years post menarche to perimenopause: <21 days or >35 days or <8 cycles per year, 1 year post menarche: >90 days for any one cycle, Primary amenorrhea: By age 15 or >3 years post thelarche (breast development).

• #15 Diagnosis and Treatment of Polycystic Ovary Syndrome | AAFP

  https://www.aafp.org/pubs/afp/issues/2016/0715/p106.html

  Polycystic ovary syndrome is the most common endocrinopathy among reproductive-aged women in the United States, affecting approximately 7% of female patients. […] Guidelines from the Endocrine Society recommend using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries, plus the exclusion of other diagnoses that could result in hyperandrogenism or ovulatory dysfunction. […] The Endocrine Society advises clinicians to diagnose PCOS using the 2003 Rotterdam criteria, although recommendations differ across guidelines. According to the Rotterdam criteria, diagnosis requires the presence of at least two of the following three findings: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries.

• #16 Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

  During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] There’s no single test to specifically diagnose polycystic ovary syndrome (PCOS). Your health care provider is likely to start with a discussion of your symptoms, medications and any other medical conditions. Your provider also may ask about your menstrual periods and any weight changes. A physical exam includes checking for signs of excess hair growth, insulin resistance and acne. […] Blood tests can measure hormone levels. This testing can exclude possible causes of menstrual problems or androgen excess that mimic PCOS. […] An ultrasound can check the appearance of your ovaries and the thickness of the lining of your uterus. […] If you have a diagnosis of PCOS, your provider might recommend more tests for complications.

• #17

  https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome

  Polycystic ovary syndrome is diagnosed by the presence of at least two out of the following: […] Blood tests can be used to identify characteristic changes in hormone levels, although these changes are not universal. […] When making a diagnosis, doctors also take into account that irregular periods and ovulation can be a normal part of puberty or menopause, having polycystic ovaries may run in families, and women with a family history of PCOS or type 2 diabetes are at higher risk of PCOS. […] In addition, the ultrasound picture is not always clear and some women with PCOS may have an ultrasound scan that does not demonstrate polycystic ovaries.

• #18 PCOS (Polycystic Ovary Syndrome): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/8316-polycystic-ovary-syndrome-pcos

  Your healthcare provider will work with you to develop a treatment plan to help you ovulate. Your treatment plan could include medication or assisted reproductive technologies like in vitro fertilization (IVF). […] Contact a healthcare provider if you suspect you have PCOS. Some signs that may point to PCOS include: An irregular menstrual cycle. Menstrual cycles are often long (longer than 40 days between periods). Excess hair growth, acne or other signs of excess androgen hormones. Difficulty getting pregnant.

• #19 Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

  During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] There’s no single test to specifically diagnose polycystic ovary syndrome (PCOS). Your health care provider is likely to start with a discussion of your symptoms, medications and any other medical conditions. Your provider also may ask about your menstrual periods and any weight changes. A physical exam includes checking for signs of excess hair growth, insulin resistance and acne. […] Blood tests can measure hormone levels. This testing can exclude possible causes of menstrual problems or androgen excess that mimic PCOS. […] An ultrasound can check the appearance of your ovaries and the thickness of the lining of your uterus. […] If you have a diagnosis of PCOS, your provider might recommend more tests for complications.

• #20 PCOS | Polycystic Ovary Syndrome | MedlinePlus

  https://medlineplus.gov/polycysticovarysyndrome.html

  How is polycystic ovary syndrome (PCOS) diagnosed? […] There is no specific test for PCOS. To find out if you have PCOS, your provider: […] Will do a physical exam, which will include looking for the physical signs of PCOS. […] Will ask about your medical history and family health history. […] May do a pelvic exam to check for signs of extra male hormones and to see if your ovaries are enlarged or swollen. […] May order a pelvic ultrasound to look for cysts on your ovaries and check the thickness of your endometrium (the lining of your uterus, or womb). […] May order blood tests, including tests to check your hormone levels.

• #21 Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

  During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] There’s no single test to specifically diagnose polycystic ovary syndrome (PCOS). Your health care provider is likely to start with a discussion of your symptoms, medications and any other medical conditions. Your provider also may ask about your menstrual periods and any weight changes. A physical exam includes checking for signs of excess hair growth, insulin resistance and acne. […] Blood tests can measure hormone levels. This testing can exclude possible causes of menstrual problems or androgen excess that mimic PCOS. […] An ultrasound can check the appearance of your ovaries and the thickness of the lining of your uterus. […] If you have a diagnosis of PCOS, your provider might recommend more tests for complications.

• #22 Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment

  https://www.healthline.com/health/polycystic-ovary-disease

  PCOS is a syndrome, or group of symptoms that affects the ovaries and ovulation. Its three main features are: high levels of male hormones, irregular or skipped periods, cysts in the ovaries. […] Doctors typically diagnose PCOS in women who have at least two of these three symptoms: high androgen levels, irregular menstrual cycles, cysts in the ovaries. […] A pelvic exam can look for any problems with your ovaries or other parts of your reproductive tract. During this test, your doctor inserts gloved fingers into your vagina and checks for any growths in your ovaries or uterus. […] Blood tests check for higher-than-normal levels of male hormones. […] You might also have blood tests to check your cholesterol, insulin, and triglyceride levels to evaluate your risk for related conditions like heart disease and diabetes.

• #23 Diagnosis and Treatment of Polycystic Ovary Syndrome | AAFP

  https://www.aafp.org/pubs/afp/issues/2016/0715/p106.html

  Diagnosis can generally be accomplished with a careful history, physical examination, and basic laboratory testing, without the need for ultrasonography or other imaging. […] The goal of further evaluation of suspected PCOS is twofold: to exclude other treatable conditions that can mimic PCOS and to detect and treat long-term metabolic complications. […] The differential diagnosis of PCOS is broad and includes both endocrinologic and malignant etiologies. […] For any woman with suspected PCOS, the Endocrine Society recommends excluding pregnancy, thyroid dysfunction, hyperprolactinemia, and nonclassical congenital adrenal hyperplasia. […] The Endocrine Society recommends clomiphene or letrozole (Femara) for ovulation induction. […] The impact of metformin on fertility is controversial; although it was once believed to improve infertility, a 2012 Cochrane review concluded that it does not.

• #24 Diagnosis and treatment of polycystic ovary syndrome (PCOS) using virtual health | This Changed My Practice (TCMP) by UBC CPD

  https://thischangedmypractice.com/diagnosis-and-treatment-pcos-using-virtual-health/

  In order to make the diagnosis, Rotterdam (2003) recommended a set of clinical, laboratory, and ultrasound investigations including: History taking for menstrual cycles and hyperandrogenism (hirsutism, acne, alopecia), 17-hydroxyprogesterone to rule out late-onset congenital adrenal hyperplasia, Thyroid-stimulating hormone (TSH), Prolactin to rule out an alternate endocrinopathy causing oligomenorrhea, Follicle-stimulating hormone (FSH) and estradiol (E2) to rule out hypogonadotropic hypogonadism (low FSH, low E2) or premature ovarian failure (high FSH, low E2), Testosterone (ideally free testosterone) +/- sex hormone binding globulin (SHBG), Androstenedione to establish hyperandrogenemia and rule out androgen-secreting neoplasms, Dihydroepiandrosteronesulfate (DHEA-S) to rule out an adrenal androgen-secreting neoplasm, Insulin resistance testing (fasting glucose and/or 2-hour 75 g oral glucose tolerance test), Transvaginal pelvic ultrasound (12 follicles 29 mm or ovarian volume 10 ml) to assess for polycystic ovary morphology.

• #25 Diagnosis and management of polycystic ovarian syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10833093/

  Biochemical hyperandrogenism is found in 60% of patients with PCOS and can be assessed using total testosterone, calculated free testosterone, dehydroepiandrosterone sulfate (DHEA-S) and androstenedione. […] If a patient meets 2 of 3 Rotterdam criteria, this satisfies criteria for PCOS diagnosis without need for laboratory confirmation of elevated androgens. […] Polycystic ovarian morphology on transvaginal ultrasonography ( 20 follicles or an ovarian volume 10 mL in at least 1 ovary) may be an additional criterion if clinical or laboratory criteria are not met.

• #26 Polycystic ovary syndrome (PCOS): Diagnosis and management – Women’s Healthcare

  https://www.npwomenshealthcare.com/polycystic-ovary-syndrome-pcos-diagnosis-and-management/

  The purpose of diagnostic laboratory tests is to identify alternate or concurrent pathologies and to screen for comorbidities. […] Laboratory assessment of biochemical hyperandrogenism has diagnostic usefulness when the clinical signs of hyperandrogenism are not evident. […] If the individual has had vaginal sexual intercourse and consents, transvaginal ultrasonography is the preferred method of evaluation for PCOM. […] The European Society for Human Reproduction and Embryology and the American Society of Reproductive Medicine met in Rotterdam in 2003 and established the Rotterdam criteria for the diagnosis of PCOS. […] The diagnostic criteria include oligo- and/or anovulation, clinical and/or biochemical indicators of hyperandrogenism, and polycystic ovaries, and two of these must be present for a diagnosis of PCOS.

• #27 What Blood Tests are Done for PCOS? – TMB – Travel Health Clinics

  https://www.tmb.ie/blog/blood-tests-pcos

  Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder that affects women of reproductive age. While the diagnosis of PCOS typically involves a comprehensive evaluation of the patients medical history, physical examination, and various diagnostic tests, blood tests play a pivotal role in confirming the condition and guiding appropriate management strategies. […] These tests should ideally be performed around Day 3 of the menstrual cycle for the most accurate results, and it is important to note that any form of hormonal contraception will affect the results. […] Elevated LH levels, often in a specific LH to FSH ratio, are a hallmark of PCOS and contribute to the pathogenesis of the syndrome. […] Elevated levels of testosterone are common in women with PCOS, contributing to symptoms such as hirsutism, acne, and male-pattern baldness.

• #28 Polycystic Ovary Syndrome (PCOS) | Clinical Focus | Quest Diagnostics Polycystic Ovary Syndrome (PCOS)Polycystic Ovary Syndrome (PCOS)

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_PCOS/polycystic-ovary-syndrome-pcos

  Importantly, PCOS can only be diagnosed once other disorders have been excluded. […] The International Evidence-Based Guideline recommends that high-quality assays, including liquid chromatography mass spectrometry-based assays, be used for the most accurate assessment of total or free testosterone in PCOS. […] Ovulatory dysfunction manifests as irregular menstrual cycles and amenorrhea. […] Ultrasound is used to identify PCOM. […] Although an ovarian ultrasound is not required to diagnose PCOS in women with irregular menstrual cycles and hyperandrogenism, it can be useful for identifying the complete PCOS phenotype. […] Women with PCOS should be assessed for a number of comorbidities associated with this condition. […] The hyperandrogenism of PCOS can persist into menopause. […] A diagnosis of PCOS postmenopause is more likely if a patient has a past diagnosis of PCOS, a long-term history of irregular menstrual cycles and hyperandrogenism, and/or PCOM during the reproductive years.

• #29 Polycystic Ovary Syndrome – PCOS | Choose the Right Test

  https://arupconsult.com/content/polycystic-ovarian-syndrome

  Although biochemical assessment for hyperandrogenemia is not always needed to diagnose PCOS, it may be helpful when clinical evidence is limited or indeterminate. The international guideline on PCOS recommends measurement of total testosterone and free testosterone to identify hyperandrogenemia. Total testosterone should be tested by tandem mass spectrometry, whereas free testosterone can be evaluated by laboratory calculation. […] In individuals with PCOS, ovulatory dysfunction (ie, oligoovulation or anovulation) may present with or without menstrual irregularity, although irregular menstrual cycles are common. When laboratory confirmation of ovulatory dysfunction is needed, serum progesterone testing should be performed during the midluteal phase of the menstrual cycle. […] Assessment for PCOM is not required in individuals who meet other biochemical or clinical criteria for PCOS; however, it may be useful to confirm a PCOS diagnosis when only one other criterion has been met. Although ultrasound has long been the standard method to detect PCOM, recent guidelines now support the use of anti-Mllerian hormone (AMH) to detect PCOM in adults, given that it has been shown to strongly correlate with antral follicle count.

• #30 Diagnosis and Treatment of Polycystic Ovary Syndrome | AAFP

  https://www.aafp.org/pubs/afp/issues/2016/0715/p106.html

  Diagnosis can generally be accomplished with a careful history, physical examination, and basic laboratory testing, without the need for ultrasonography or other imaging. […] The goal of further evaluation of suspected PCOS is twofold: to exclude other treatable conditions that can mimic PCOS and to detect and treat long-term metabolic complications. […] The differential diagnosis of PCOS is broad and includes both endocrinologic and malignant etiologies. […] For any woman with suspected PCOS, the Endocrine Society recommends excluding pregnancy, thyroid dysfunction, hyperprolactinemia, and nonclassical congenital adrenal hyperplasia. […] The Endocrine Society recommends clomiphene or letrozole (Femara) for ovulation induction. […] The impact of metformin on fertility is controversial; although it was once believed to improve infertility, a 2012 Cochrane review concluded that it does not.

• #31 Diagnosis and treatment of polycystic ovary syndrome (PCOS) using virtual health | This Changed My Practice (TCMP) by UBC CPD

  https://thischangedmypractice.com/diagnosis-and-treatment-pcos-using-virtual-health/

  In order to make the diagnosis, Rotterdam (2003) recommended a set of clinical, laboratory, and ultrasound investigations including: History taking for menstrual cycles and hyperandrogenism (hirsutism, acne, alopecia), 17-hydroxyprogesterone to rule out late-onset congenital adrenal hyperplasia, Thyroid-stimulating hormone (TSH), Prolactin to rule out an alternate endocrinopathy causing oligomenorrhea, Follicle-stimulating hormone (FSH) and estradiol (E2) to rule out hypogonadotropic hypogonadism (low FSH, low E2) or premature ovarian failure (high FSH, low E2), Testosterone (ideally free testosterone) +/- sex hormone binding globulin (SHBG), Androstenedione to establish hyperandrogenemia and rule out androgen-secreting neoplasms, Dihydroepiandrosteronesulfate (DHEA-S) to rule out an adrenal androgen-secreting neoplasm, Insulin resistance testing (fasting glucose and/or 2-hour 75 g oral glucose tolerance test), Transvaginal pelvic ultrasound (12 follicles 29 mm or ovarian volume 10 ml) to assess for polycystic ovary morphology.

• #32 Polycystic Ovarian Syndrome: Practice Essentials, Background, Etiology

  https://emedicine.medscape.com/article/256806-overview

  Exclude all other disorders that can result in menstrual irregularity and hyperandrogenism, including adrenal or ovarian tumors, thyroid dysfunction, congenital adrenal hyperplasia, hyperprolactinemia, acromegaly, and Cushing syndrome. […] Baseline screening laboratory studies for women suspected of having PCOS may include the following: Thyroid function tests (eg, TSH, free thyroxine), Serum prolactin level, Total and free testosterone levels, Free androgen index, Serum hCG level, Cosyntropin stimulation test, Serum 17-hydroxyprogesterone (17-OHPG) level, Urinary free cortisol (UFC) and creatinine levels, Low-dose dexamethasone suppression test, Serum insulin-like growth factor (IGF)1 level. […] Other tests used in the evaluation of PCOS include the following: Androstenedione level, FSH and LH levels, GnRH stimulation testing, Glucose level, Insulin level, Lipid panel.

• #33 PCOS (Polycystic Ovary Syndrome) Diagnosis & Blood Tests

  https://www.webmd.com/women/do-i-have-pcos

  Anti-Mullerian hormone (AMH): This test can check how well your ovaries are working and to help estimate how far off menopause may be. The levels would be higher with PCOS. […] Your doctor may recommend a few more tests to rule out other conditions such as thyroid problems, tumors, and hyperplasia (organ-swelling due to too many cells) that have similar symptoms to PCOS. […] If you have PCOS, you then may get a blood glucose and cholesterol test. Doctors often do these tests to check on your overall health and chance of having other conditions: Lipid profiles checks your cholesterol and triglycerides. PCOS can make you more likely to develop heart disease. Glucose test helps to see if you have diabetes. More than half of women who have PCOS get this disease. Insulin: Your doctor will want to find out how well your body responds to insulin, which helps control your blood sugar level. If your body doesnt respond to the insulin its making, you may have insulin resistance. Its common among women with PCOS and can lead to diabetes.

• #34 Polycystic Ovarian Syndrome: Practice Essentials, Background, Etiology

  https://emedicine.medscape.com/article/256806-overview

  Exclude all other disorders that can result in menstrual irregularity and hyperandrogenism, including adrenal or ovarian tumors, thyroid dysfunction, congenital adrenal hyperplasia, hyperprolactinemia, acromegaly, and Cushing syndrome. […] Baseline screening laboratory studies for women suspected of having PCOS may include the following: Thyroid function tests (eg, TSH, free thyroxine), Serum prolactin level, Total and free testosterone levels, Free androgen index, Serum hCG level, Cosyntropin stimulation test, Serum 17-hydroxyprogesterone (17-OHPG) level, Urinary free cortisol (UFC) and creatinine levels, Low-dose dexamethasone suppression test, Serum insulin-like growth factor (IGF)1 level. […] Other tests used in the evaluation of PCOS include the following: Androstenedione level, FSH and LH levels, GnRH stimulation testing, Glucose level, Insulin level, Lipid panel.

• #35 Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

  During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] There’s no single test to specifically diagnose polycystic ovary syndrome (PCOS). Your health care provider is likely to start with a discussion of your symptoms, medications and any other medical conditions. Your provider also may ask about your menstrual periods and any weight changes. A physical exam includes checking for signs of excess hair growth, insulin resistance and acne. […] Blood tests can measure hormone levels. This testing can exclude possible causes of menstrual problems or androgen excess that mimic PCOS. […] An ultrasound can check the appearance of your ovaries and the thickness of the lining of your uterus. […] If you have a diagnosis of PCOS, your provider might recommend more tests for complications.

• #36 Polycystic Ovary Syndrome (PCOS) Imaging: Practice Essentials, Magnetic Resonance Imaging, Ultrasonography

  https://emedicine.medscape.com/article/404754-overview

  In polycystic ovary syndrome (PCOS), enlarged ovaries with thickened sclerotic capsules and an abnormally high number of follicles are present. The American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society have published best practices for evaluating and treating PCOS. They state that the diagnosis of PCOS is based on the presence of at least 2 of the following 3 criteria: chronic anovulation, hyperandrogenism (clinical or biological), and polycystic ovaries. […] PCOS is usually diagnosed based on the Rotterdam criteria if 2 of 3 criteria are present: (1) oligo- and/or anovulation, (2) hyperandrogenism (HA) (clinical and/or biochemical), and (3) polycystic ovary morphology (PCOM) on ultrasonography (either 12 or more follicles measuring 2-9 mm in diameter and/or an increased ovarian volume 10 cm3).

• #37 Diagnosis and management of polycystic ovarian syndrome

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10833093/

  Biochemical hyperandrogenism is found in 60% of patients with PCOS and can be assessed using total testosterone, calculated free testosterone, dehydroepiandrosterone sulfate (DHEA-S) and androstenedione. […] If a patient meets 2 of 3 Rotterdam criteria, this satisfies criteria for PCOS diagnosis without need for laboratory confirmation of elevated androgens. […] Polycystic ovarian morphology on transvaginal ultrasonography ( 20 follicles or an ovarian volume 10 mL in at least 1 ovary) may be an additional criterion if clinical or laboratory criteria are not met.

• #38 Polycystic Ovary Syndrome (PCOS) Imaging: Practice Essentials, Magnetic Resonance Imaging, Ultrasonography

  https://emedicine.medscape.com/article/404754-overview

  According to the Rotterdam consensus and Androgen Excess PCOS Society, ultrasound criteria consist of the presence of 12 or more follicles within the ovary, with a diameter of 2-9 mm and/or ovarian volume 10 cm3 or greater. […] Polycystic ovaries are most often diagnosed by means of laboratory studies. […] Typically, a radiologic evaluation for polycystic ovaries is reserved for patients who have equivocal laboratory findings. […] Should the radiologist’s assistance be requested in the diagnosis of polycystic ovary syndrome, the imaging method of choice is transabdominal and/or transvaginal ultrasonography. […] In a case-control study, by Fondin et al of 110 adolescent girls (age range, 13-17 yr) who underwent pelvic MR imaging, the most accurate diagnostic criteria on MRI for PCOS were ovarian volume, follicles per ovary measuring 9 mm or less, and peripheral distribution of follicles. […] Ultrasonography has a largely corroborative role in the diagnosis of polycystic ovary syndrome. […] Ultimately, the diagnosis should be made on clinical and biochemical grounds. However, normal ultrasonographic findings should not exclude the diagnosis.

• #39 Ultrasound Assessment in Polycystic Ovary Syndrome Diagnosis: From Origins to Future Perspectives—A Comprehensive Review

  https://www.mdpi.com/2227-9059/13/2/453

  A TV-US is generally preferred over a transabdominal ultrasound (TA-US) in assessing ovarian morphology due to its higher resolution, closer proximity to the ovaries, and superior ability to delineate follicular structures. […] The ovarian volume (OV) can be calculated via the ellipsoid formula on standard ultrasound systems or with three-dimensional approaches. […] Diagnosis of PCOM relies chiefly on OV, FNPS, and FNPO. […] One of the earliest and most frequently cited ultrasound definitions of polycystic ovaries was introduced by Adams et al. (1985), who used ≥10 follicles (2–8 mm) in a single cross-section of the ovary on transabdominal ultrasound. […] The latest Evidence-Based Guidelines then put forward ≥20 follicles as a compromise, underscoring that definitive sensitivity/specificity values for either 25 or 20 follicles remain under continuous investigation.

• #40 Polycystic ovarian syndrome | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/polycystic-ovarian-syndrome-1?lang=us

  Anti-Mullerian hormone (AMH) levels are generally increased, and there is emerging evidence for the utility of AMH in the diagnosis of PCOS. […] The specific diagnostic cut-offs, however, have been the subject of debate and revision. The updated diagnostic criteria (c. 2024) are based on a 2023 international consensus guideline and supersede the 2003 Rotterdam criteria of 12 follicles and interim recommendations of 25 follicles. […] The diagnostic criteria are adjusted in adolescent females (defined as within 8 years of menarche, or age 20 years), in whom ultrasound should not be used for the diagnosis of PCOS due to the high incidence of multi-follicular ovaries in this life stage. […] Postmenopausal women presenting with new-onset, severe or worsening hyperandrogenism including hirsutism, require further investigation to rule out androgen-secreting tumors and ovarian hyperthecosis.

• #41 Diagnosing and treating PCOS | Jean Hailes

  https://www.jeanhailes.org.au/health-a-z/polycystic-ovary-syndrome/diagnosing-and-treating-pcos

  A blood test for anti-mullerian hormone (AMH) level can be done instead of an ultrasound. […] You dont need to have an ultrasound to confirm PCOS if you have irregular or no periods and high androgen levels. […] Ultrasounds are not recommended for women under 20 years of age. […] Your doctor may ask you to do different tests before they confirm a PCOS diagnosis. The tests will depend on your individual symptoms. […] Blood tests for testosterone and free androgen index (FAI) can identify high androgen levels. […] Your doctor may also recommend blood tests to exclude conditions with similar symptoms to PCOS. […] Your doctor or specialist may perform an abdominal ultrasound to check for signs of PCOS (e.g. partly-developed eggs on your ovaries, enlarged ovaries or a thickened uterus lining).

• #42 Polycystic Ovarian Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK459251/

  Newer criteria from the International Evidence-Based Guideline for the Assessment and Management of PCOS 2023 recommend that an adult diagnosis of PCOS requires the presence of 2 out of the following 3 criteria, as well as the exclusion of differential diagnoses with similar clinical features: Clinical or biochemical hyperandrogenism, Ovulatory dysfunction, Findings of polycystic ovaries on ultrasound or elevated AMH levels. […] When irregular menstrual cycles and hyperandrogenism are present, neither ultrasound nor AMH testing is necessary for the diagnosis of PCOS in adults. […] Excluding disorders that can mimic the clinical features of PCOS is also essential, including thyroid disease, hyperprolactinemia, and atypical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

• #43 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  The guideline provides 77 evidence-based and 54 consensus recommendations, with 123 practice points underpinned by a technical report on evidence synthesis and GRADE detailed considerations. […] Key recommendations and updates include that PCOS should be diagnosed using the 2018 International Evidence-based Guideline criteria, which built on the consensus based 2003 Rotterdam criteria. […] This requires the presence of two of the following: i) clinical / biochemical hyperandrogenism; ii) ovulatory dysfunction; and iii) polycystic ovaries on ultrasound; and here in 2023, alternatively anti-Mullerian hormone (AMH) can now be used instead of ultrasound, with the exclusion of other aetiologies. […] Importantly, where irregular menstrual cycles and hyperandrogenism are present, diagnosis is simplified and ultrasound or AMH are not required for diagnosis.

• #44 Polycystic Ovary Syndrome: Assessment and Management Guidelines | AAFP

  https://www.aafp.org/pubs/afp/issues/2024/1100/practice-guidelines-polycystic-ovary-syndrome.html

  PCOS can be diagnosed without using ultrasonography in women with ovulatory dysfunction and clinical or biochemical evidence of hyperandrogenism. […] In adults, antimllerian hormone levels can be used instead of ultrasonography to indicate polycystic ovaries. […] To diagnose PCOS, two of the following criteria are required: clinical or biochemical evidence of hyperandrogenism, ovulatory dysfunction, ultrasound images showing polycystic ovaries or elevated antimllerian hormone levels. […] At least 60% of women with PCOS have evidence of hyperandrogenism using clinical or biochemical markers.

• #45 Polycystic ovary syndrome (PCOS) | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/polycystic-ovarian-syndrome-pcos

  Polycystic ovary syndrome (PCOS) is a complex hormonal condition that affects about 10% of women. […] Early diagnosis and support from a team of health professionals can reduce symptoms. […] If you have symptoms of PCOS, see your doctor. Early diagnosis and support from a team of health practitioners can reduce symptoms and prevent long-term health problems. […] When you see your doctor, they will ask questions about your symptoms and medical history. They may also order blood tests and an ultrasound to learn more. […] Sometimes polycystic ovaries can be seen on an ultrasound, but you dont need an ultrasound to confirm PCOS. […] PCOS may be diagnosed if you have 2 or more of the following symptoms: irregular or absent periods, acne, excess facial or body hair, scalp hair loss, or high levels of androgens in the blood, polycystic ovaries (more than 20 small, underdeveloped eggs on the ovaries) visible on an ultrasound. […] A blood test for anti-mullerian hormone (AMH) level can be done instead of an ultrasound.

• #46 Diagnosis and treatment of polycystic ovary syndrome (PCOS) using virtual health | This Changed My Practice (TCMP) by UBC CPD

  https://thischangedmypractice.com/diagnosis-and-treatment-pcos-using-virtual-health/

  The 2018 guideline presents a more clinical approach to diagnosis of PCOS. Laboratory and ultrasound investigations are limited and the primary focus is on appropriate diagnosis and management. I find the algorithm amenable to a virtual health diagnosis in most cases of PCOS. […] I also find it very helpful to order serum Anti-Mllerian Hormone (AMH) when assessing for PCOS in a virtual health setting. AMH is produced by granulosa cells, which surround each small follicle in the ovary. Hence, a high AMH value indicates the presence of a high number of ovarian follicles. AMH is not yet considered a substitute for polycystic ovary morphology on ultrasound (i.e., you cannot establish that there are 20 follicles per ovary using this single test). However, there is increasing evidence that high, age-specific AMH levels can be used as diagnostic markers. I order AMH testing on most patients, especially if there is limited access to transvaginal ultrasound. For example, AMH can quickly differentiate between PCOS (high AMH) and perimenopause (low AMH, 8 pmol/L) as causes of oligomenorrhea.

• #47 Polycystic Ovary Syndrome – PCOS | Choose the Right Test

  https://arupconsult.com/content/polycystic-ovarian-syndrome

  In individuals without clinical signs of hyperandrogenemia (eg, hirsutism), assessment of free and total testosterone is recommended. Total testosterone should be tested by tandem mass spectrometry, whereas free testosterone can be evaluated by laboratory calculation. […] Yes. Recent guidelines support the use of serum anti-Mllerian hormone (AMH) testing to evaluate for polycystic ovary morphology (PCOM) in adults when evidence of PCOM is needed for diagnosis of polycystic ovary syndrome (PCOS). Notably, evidence of PCOM is not required for diagnosis when two other diagnostic criteria for PCOS are met. […] Guidelines recommend use of either serum AMH or ultrasound (not both) to evaluate for PCOM. In adolescents (defined as those fewer than 8 years postmenarche), testing for PCOM is not recommended, regardless of method.

• #48 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  In adolescents, both hyperandrogenism and ovulatory dysfunction are required, with ultrasound and AMH not recommended due to poor specificity. […] Insulin resistance is recognized as a key feature of PCOS, yet routinely available measures of insulin resistance are inaccurate and clinical measurement is not currently recommended. […] Once diagnosed, assessment and management should address reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features. […] A lifelong health plan is recommended including a focus on healthy lifestyle, prevention of excess weight gain, optimization of fertility and preconception risk factors, and prevention and treatment of diverse clinical features. […] These include metabolic risk factors, diabetes, cardiovascular disease, and sleep disorders, which are all increased in PCOS.

• #49 Polycystic Ovary Syndrome – PCOS | Choose the Right Test

  https://arupconsult.com/content/polycystic-ovarian-syndrome

  In individuals without clinical signs of hyperandrogenemia (eg, hirsutism), assessment of free and total testosterone is recommended. Total testosterone should be tested by tandem mass spectrometry, whereas free testosterone can be evaluated by laboratory calculation. […] Yes. Recent guidelines support the use of serum anti-Mllerian hormone (AMH) testing to evaluate for polycystic ovary morphology (PCOM) in adults when evidence of PCOM is needed for diagnosis of polycystic ovary syndrome (PCOS). Notably, evidence of PCOM is not required for diagnosis when two other diagnostic criteria for PCOS are met. […] Guidelines recommend use of either serum AMH or ultrasound (not both) to evaluate for PCOM. In adolescents (defined as those fewer than 8 years postmenarche), testing for PCOM is not recommended, regardless of method.

• #50 Polycystic Ovary Syndrome (PCOS) (for Teens) | Nemours KidsHealth

  https://kidshealth.org/en/teens/pcos.html

  Polycystic ovary syndrome (PCOS) is a common health problem that can affect teen girls and young women. […] PCOS cannot be diagnosed until 23 years after a girls first menstrual cycle because it can take up to 2 years after a first period for any girl’s cycle to become regular. […] If your doctor thinks you might have PCOS, they might want you to see a gynecologist or an endocrinologist for a diagnosis. […] Doctors sometimes order blood tests to diagnose PCOS and or to see if the symptoms are caused by other conditions, such as thyroid or other ovarian or gland problems. […] Your doctor might order a pelvic ultrasound to check your ovaries for cysts or other problems.

• #51 Diagnosing Polycystic Ovary Syndrome in Adolescents | NYU Langone Health

  https://nyulangone.org/conditions/polycystic-ovary-syndrome-in-adolescents/diagnosis

  Endocrinologists at Hassenfeld Childrens Hospital at NYU Langone are experienced in diagnosing adolescent girls with polycystic ovary syndrome (PCOS), which affects the development and function of the ovaries. […] To diagnose PCOS, our specialists conduct a physical exam and perform blood and imaging tests. […] During a physical exam, the doctor measures your daughters height and weight and may check the distribution of fat around her abdomen to determine if she is overweight. […] The doctor may order blood tests to measure androgen and insulin levels, which are higher than normal in women with PCOS. […] Blood tests are also used to rule out conditions that can cause symptoms similar to those of PCOS. […] Your childs doctor may recommend a pelvic ultrasound to evaluate the size and appearance of the ovaries.

• #52 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  In adolescents, both hyperandrogenism and ovulatory dysfunction are required, with ultrasound and AMH not recommended due to poor specificity. […] Insulin resistance is recognized as a key feature of PCOS, yet routinely available measures of insulin resistance are inaccurate and clinical measurement is not currently recommended. […] Once diagnosed, assessment and management should address reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features. […] A lifelong health plan is recommended including a focus on healthy lifestyle, prevention of excess weight gain, optimization of fertility and preconception risk factors, and prevention and treatment of diverse clinical features. […] These include metabolic risk factors, diabetes, cardiovascular disease, and sleep disorders, which are all increased in PCOS.

• #53 Polycystic Ovary Syndrome – PCOS | Choose the Right Test

  https://arupconsult.com/content/polycystic-ovarian-syndrome

  Polycystic ovary syndrome (PCOS) is a common hormonal and metabolic disorder characterized by a combination of ovulatory dysfunction, clinical hyperandrogenism, biochemical hyperandrogenism (ie, hyperandrogenemia), and polycystic ovary morphology (PCOM). PCOS is a diagnosis of exclusion, and laboratory testing is required to rule out other potential etiologies. Testing may also be useful to assess for biochemical hyperandrogenism, ovulatory dysfunction, and/or PCOM when clinical evidence is not sufficient to issue a diagnosis. […] Diagnostic testing for polycystic ovary syndrome (PCOS) is largely the same in adults and adolescents, except when assessment for polycystic ovary morphology (PCOM) is necessary for diagnosis. Currently, guidelines recommend against PCOM testing (ie, ultrasound and serum anti-Mllerian hormone testing) in adolescents.

• #54 Polycystic ovarian syndrome | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/polycystic-ovarian-syndrome-1?lang=us

  Anti-Mullerian hormone (AMH) levels are generally increased, and there is emerging evidence for the utility of AMH in the diagnosis of PCOS. […] The specific diagnostic cut-offs, however, have been the subject of debate and revision. The updated diagnostic criteria (c. 2024) are based on a 2023 international consensus guideline and supersede the 2003 Rotterdam criteria of 12 follicles and interim recommendations of 25 follicles. […] The diagnostic criteria are adjusted in adolescent females (defined as within 8 years of menarche, or age 20 years), in whom ultrasound should not be used for the diagnosis of PCOS due to the high incidence of multi-follicular ovaries in this life stage. […] Postmenopausal women presenting with new-onset, severe or worsening hyperandrogenism including hirsutism, require further investigation to rule out androgen-secreting tumors and ovarian hyperthecosis.

• #55 Diagnosis and treatment of polycystic ovary syndrome (PCOS): An interview with Richard Legro | BMC Medicine | Full Text

  https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0299-2

  In this podcast, we talk to Professor Richard Legro about the recommendations for the diagnosis and treatment of polycystic ovary syndrome (PCOS) based on clinical practice guidelines and discuss the challenges of diagnosis PCOS at specific age groups. […] We recommended that the so-called Rotterdam criteria should be used to diagnose PCOS. Those criteria are based on finding two of the three cardinal features that characterize PCOS. […] If you have two or three of the conditions indicated above, you qualify for the diagnosis of polycystic ovary syndrome. […] All the criteria agree that you should exclude common conditions that may mimic some of the signs and symptoms of polycystic ovary syndrome. […] In regards to the question about the specific challenges associated with adolescent and menopausal women, I think it is difficult or nearly impossible to diagnose it in adolescent and menopausal women.

• #56 Polycystic Ovary Syndrome – PCOS | Choose the Right Test

  https://arupconsult.com/content/polycystic-ovarian-syndrome

  Following the exclusion of other etiologies, evidence of both ovulatory dysfunction and hyperandrogenism is required to issue a PCOS diagnosis in adolescents. Laboratory testing for ovulatory dysfunction and biochemical hyperandrogenism may play a greater role if clinical evidence is lacking or indeterminate. […] Because changes in ovulation, hormone concentrations, and ovary morphology are typical in menopause, diagnosis of polycystic ovary syndrome (PCOS) in menopausal or postmenopausal individuals may need to be based on patient history and previous clinical or biochemical evidence (as detailed in the Clinical Assessment and Laboratory Testing sections). […] The Rotterdam criteria for diagnosis are recommended in postmenopausal adults. However, further investigation is needed to characterize the typical features and findings associated with menopausal/postmenopausal PCOS.

• #57 Polycystic Ovary Syndrome – PCOS | Choose the Right Test

  https://arupconsult.com/content/polycystic-ovarian-syndrome

  Following the exclusion of other etiologies, evidence of both ovulatory dysfunction and hyperandrogenism is required to issue a PCOS diagnosis in adolescents. Laboratory testing for ovulatory dysfunction and biochemical hyperandrogenism may play a greater role if clinical evidence is lacking or indeterminate. […] Because changes in ovulation, hormone concentrations, and ovary morphology are typical in menopause, diagnosis of polycystic ovary syndrome (PCOS) in menopausal or postmenopausal individuals may need to be based on patient history and previous clinical or biochemical evidence (as detailed in the Clinical Assessment and Laboratory Testing sections). […] The Rotterdam criteria for diagnosis are recommended in postmenopausal adults. However, further investigation is needed to characterize the typical features and findings associated with menopausal/postmenopausal PCOS.

• #58 Polycystic ovary syndrome | Quest Diagnostics

  https://www.questdiagnostics.com/healthcare-professionals/about-our-tests/endocrine-disorders/polycystic-ovarian-syndrome

  Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder in reproductive-aged women. […] PCOS is a complex condition that can only be diagnosed by eliminating other disorders with similar symptoms. […] Since no single criterion or test can be used to diagnose PCOS, diagnosis is primarily based on the exclusion of diseases with similar symptoms. […] The 2003 Rotterdam criteria are the most-used approach for diagnosis of PCOS; the Rotterdam consensus defines PCOS based on the presence of at least 2 of 3 criteria: hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology (PCOM). […] Once a phenotype has been identified, it is necessary to exclude other disorders to make a diagnosis. […] Individuals suitable for testing: Adolescent girls with hyperandrogenism (clinical or biochemical) and persistent ovulatory dysfunction; Women of reproductive age with 2 of the following criteria: Hyperandrogenism (clinical or biochemical), Ovulatory dysfunction, Polycystic ovaries; Perimenopausal and menopausal individuals with a well-documented, long-term history of hyperandrogenism (clinical or biochemical) and ovulatory dysfunction.

• #59 Polycystic Ovary Syndrome (PCOS) | Clinical Focus | Quest Diagnostics Polycystic Ovary Syndrome (PCOS)Polycystic Ovary Syndrome (PCOS)

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_PCOS/polycystic-ovary-syndrome-pcos

  Importantly, PCOS can only be diagnosed once other disorders have been excluded. […] The International Evidence-Based Guideline recommends that high-quality assays, including liquid chromatography mass spectrometry-based assays, be used for the most accurate assessment of total or free testosterone in PCOS. […] Ovulatory dysfunction manifests as irregular menstrual cycles and amenorrhea. […] Ultrasound is used to identify PCOM. […] Although an ovarian ultrasound is not required to diagnose PCOS in women with irregular menstrual cycles and hyperandrogenism, it can be useful for identifying the complete PCOS phenotype. […] Women with PCOS should be assessed for a number of comorbidities associated with this condition. […] The hyperandrogenism of PCOS can persist into menopause. […] A diagnosis of PCOS postmenopause is more likely if a patient has a past diagnosis of PCOS, a long-term history of irregular menstrual cycles and hyperandrogenism, and/or PCOM during the reproductive years.

• #60 Polycystic Ovary Syndrome Diagnosis: The Promise of Artificial Intelligence for Improved Clinical Accuracy – Biomedical and Pharmacology Journal

  https://biomedpharmajournal.org/vol18no1/polycystic-ovary-syndrome-diagnosis-the-promise-of-artificial-intelligence-for-improved-clinical-accuracy/

  Diagnosing PCOS is a challenging task for many reasons. […] Different diagnostic criteria among guidelines, such as Rotterdam and NIH criteria, are variable. […] Overlapping symptoms with other conditions such as hypothyroidism and metabolic syndrome make the correct identification of the disease a very challenging task. […] The lack of reliable biomarkers for early detection limits objective diagnostic tools. […] While such traditional diagnostic criteria of NIH guidelines and the Rotterdam criteria have served as guidelines to help with the diagnosis of PCOS, the new innovations, such as technological advancements from AI (Artificial Intelligence) and ML (Machine Learning), open up the possibilities for increasing the accuracy in the early diagnosis. […] AI has been identified as a transformative tool in the detection of PCOS by analyzing complex clinical, biochemical, and imaging datasets with high precision.

• #61 Current Guidelines for Diagnosing PCOS

  https://www.mdpi.com/2075-4418/13/6/1113

  It is recommended to use the modified Rotterdam criteria, in which PCOS may be diagnosed if any two of the following are present: (1) clinical or biochemical hyperandrogenism, (2) evidence of oligo-anovulation, (3) polycystic appearing-ovarian morphology on ultrasound, with exclusion of other relevant disorders. […] Diagnosis of PCOS should not be given lightly. Receiving a diagnosis of this syndrome is associated with significant psychological distress, reduced well-being, depression, and fears about future health and fertility. […] Given the continued debate over criteria, and the often inadequate clinical care using the current framework for diagnosis of PCOS, it begs the question: after almost 20 years, is it time to revisit this diagnosis?

• #62

  https://www.gleneagles.com.sg/conditions-diseases/polycystic-ovary-syndrome/diagnosis-treatment

  PCOS can be exceptionally tricky to diagnose, especially in adolescents and menopausal women who experience normal hormonal changes. […] Your doctor will discuss your medical history, menstrual period, weight changes and symptoms. To confirm a diagnosis, your doctor may order: […] Your doctor may diagnose you with PCOS if you have at least 3 of the following criteria: […] With the proper diagnosis, treatment and lifestyle changes, PCOS can be managed.

• #63 Polycystic Ovary Syndrome Diagnosis: The Promise of Artificial Intelligence for Improved Clinical Accuracy – Biomedical and Pharmacology Journal

  https://biomedpharmajournal.org/vol18no1/polycystic-ovary-syndrome-diagnosis-the-promise-of-artificial-intelligence-for-improved-clinical-accuracy/

  Machine learning and deep learning algorithms can identify subtle patterns in data that may not be recognized by traditional diagnostic methods, thereby allowing for early and accurate diagnosis. […] These technologies do not only enhance the accuracy of diagnosis but also provide for personalized treatment strategies in order to effectively deal with the heterogeneous nature of PCOS. […] The integration of AI and ML into diagnosis presents the possibility of revolutionizing the management process of PCOS. […] These technologies not only fill the gaps of conventional techniques but also give earlier and more accurate diagnoses, which have been considered a major medical tool for the betterment of outcomes in patients with PCOS across the varying phenotypes and stages in life. […] AI-guided diagnostic instruments can better take care of the complexity of PCOS, which allows health care strategies to be proactive rather than reactive and transform the entire horizon of management of PCOS.

• #64 Polycystic Ovary Syndrome Diagnosis: The Promise of Artificial Intelligence for Improved Clinical Accuracy – Biomedical and Pharmacology Journal

  https://biomedpharmajournal.org/vol18no1/polycystic-ovary-syndrome-diagnosis-the-promise-of-artificial-intelligence-for-improved-clinical-accuracy/

  PCOS diagnosis becomes even more challenging in adolescence and during the menopausal transition. […] Therefore, an adaptive and dynamic diagnostic approach is the need of the hour for women of all ages. […] This study aims at giving a comprehensive review of the literature covering the integration of Artificial Intelligence and Machine Learning techniques for the early and accurate detection of Polycystic Ovary Syndrome. […] AI tools were applied to predict PCOS using different machine learning and deep learning classifiers. […] These models obtained high-performance metrics; in all cases accuracy, precision, recall, and F1-score were well above 98%. […] AI-driven methods are now fast becoming the backbone in both diagnosis and prognosis. […] The possibility of using AI and machine learning for the diagnosis of PCOS has led to the emergence of fast, accurate, and interpretable methods that have improved our ability to respond to the healthcare burden imposed by the disorder.

• #65 A diagnostic model for polycystic ovary syndrome based on machine learning | Scientific Reports

  https://www.nature.com/articles/s41598-025-92630-4

  In this study, five classification models based on machine learning algorithms were successfully constructed. Combining the evaluation metrics of each model performance, we concluded that the logistic classification model had the best performance capability in our study. […] The results suggested that the model with the largest AUC was the logistic classification model at 0.934, the XG Boost model had the highest diagnostic accuracy and sensitivity at 0.905 and 0.870, respectively, the model with the highest specificity was the logistic classification model at 0.947 and the logistic classification model had the highest F1 score at 0.864. […] This indicates that not only did the Logistic classification model demonstrate superior overall efficacy in our study, but it also possesses good applicability.

• #66 Polycystic Ovary Syndrome Diagnosis: The Promise of Artificial Intelligence for Improved Clinical Accuracy – Biomedical and Pharmacology Journal

  https://biomedpharmajournal.org/vol18no1/polycystic-ovary-syndrome-diagnosis-the-promise-of-artificial-intelligence-for-improved-clinical-accuracy/

  PCOS diagnosis becomes even more challenging in adolescence and during the menopausal transition. […] Therefore, an adaptive and dynamic diagnostic approach is the need of the hour for women of all ages. […] This study aims at giving a comprehensive review of the literature covering the integration of Artificial Intelligence and Machine Learning techniques for the early and accurate detection of Polycystic Ovary Syndrome. […] AI tools were applied to predict PCOS using different machine learning and deep learning classifiers. […] These models obtained high-performance metrics; in all cases accuracy, precision, recall, and F1-score were well above 98%. […] AI-driven methods are now fast becoming the backbone in both diagnosis and prognosis. […] The possibility of using AI and machine learning for the diagnosis of PCOS has led to the emergence of fast, accurate, and interpretable methods that have improved our ability to respond to the healthcare burden imposed by the disorder.

• #67 A diagnostic model for polycystic ovary syndrome based on machine learning | Scientific Reports

  https://www.nature.com/articles/s41598-025-92630-4

  In this study, five classification models based on machine learning algorithms were successfully constructed. Combining the evaluation metrics of each model performance, we concluded that the logistic classification model had the best performance capability in our study. […] The results suggested that the model with the largest AUC was the logistic classification model at 0.934, the XG Boost model had the highest diagnostic accuracy and sensitivity at 0.905 and 0.870, respectively, the model with the highest specificity was the logistic classification model at 0.947 and the logistic classification model had the highest F1 score at 0.864. […] This indicates that not only did the Logistic classification model demonstrate superior overall efficacy in our study, but it also possesses good applicability.

• #68 PCOS Diagnosis — PCOS Awareness Association

  https://www.pcosaa.org/pcos-diagnosis

  An early diagnosis can help women with PCOS restore fertility, normalize their menstrual cycles, and protect against polycystic ovary syndrome-related risks for diabetes, heart disease, and endometrial cancer. […] Irregular menstrual periods caused by a lack of ovulation or by irregular ovulation. Periods more than 35 days apart are a strong sign of ovulation problems. […] Higher than normal androgen levels. Your doctor may look for physical signs of high levels of testosterone excess hair, male-pattern hair loss, and severe acne or use the results of blood tests. […] Polycystic ovaries on pelvic ultrasound. Thanks to newer, more sensitive ultrasound equipment, experts say doctors should look for 25 or more cysts on a woman’s ovary to diagnose polycystic ovaries.

• #69 Polycystic Ovarian Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK459251/

  Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder among females of reproductive age worldwide. […] PCOS is based on the presence of diagnostic criteria. […] This course explores the complexities surrounding PCOS, including the current diagnostic challenges and multifactorial pathophysiology, exploring the role of insulin resistance and hormonal abnormalities. […] Delayed diagnosis can contribute to complications, making timely lifestyle interventions crucial for symptom management and improving quality of life. […] Most society guidelines have accepted that PCOS may be diagnosed if 2 out of the 3 following clinical criteria are present: chronic oligo-anovulation, clinical or biological hyperandrogenism, and PCOM in the absence of any other pathology, which are part of the Rotterdam Criteria.

• #70 Polycystic ovary syndrome – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/polycystic-ovary-syndrome/

  Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women. The diagnosis involves a complete history and physical examination to evaluate for ovulatory dysfunction and clinical signs of hyperandrogenism. Laboratory tests are performed to confirm biochemical hyperandrogenism and exclude other conditions with a potentially similar clinical picture (e.g., congenital adrenal hyperplasia). […] Early diagnosis is essential, as PCOS is associated with many conditions, including metabolic dysfunction and impaired fertility. It also has a significant impact on a woman’s emotional well-being and quality of life. […] Suspect PCOS in women of reproductive age with features of hyperandrogenism and/or ovulatory dysfunction. […] Use the Rotterdam criteria to establish the clinical diagnosis.

• #71 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  The guideline provides 77 evidence-based and 54 consensus recommendations, with 123 practice points underpinned by a technical report on evidence synthesis and GRADE detailed considerations. […] Key recommendations and updates include that PCOS should be diagnosed using the 2018 International Evidence-based Guideline criteria, which built on the consensus based 2003 Rotterdam criteria. […] This requires the presence of two of the following: i) clinical / biochemical hyperandrogenism; ii) ovulatory dysfunction; and iii) polycystic ovaries on ultrasound; and here in 2023, alternatively anti-Mullerian hormone (AMH) can now be used instead of ultrasound, with the exclusion of other aetiologies. […] Importantly, where irregular menstrual cycles and hyperandrogenism are present, diagnosis is simplified and ultrasound or AMH are not required for diagnosis.

• #72 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  In adolescents, both hyperandrogenism and ovulatory dysfunction are required, with ultrasound and AMH not recommended due to poor specificity. […] Insulin resistance is recognized as a key feature of PCOS, yet routinely available measures of insulin resistance are inaccurate and clinical measurement is not currently recommended. […] Once diagnosed, assessment and management should address reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features. […] A lifelong health plan is recommended including a focus on healthy lifestyle, prevention of excess weight gain, optimization of fertility and preconception risk factors, and prevention and treatment of diverse clinical features. […] These include metabolic risk factors, diabetes, cardiovascular disease, and sleep disorders, which are all increased in PCOS.

• #73 Current Guidelines for Diagnosing PCOS

  https://www.mdpi.com/2075-4418/13/6/1113

  It is recommended to use the modified Rotterdam criteria, in which PCOS may be diagnosed if any two of the following are present: (1) clinical or biochemical hyperandrogenism, (2) evidence of oligo-anovulation, (3) polycystic appearing-ovarian morphology on ultrasound, with exclusion of other relevant disorders. […] Diagnosis of PCOS should not be given lightly. Receiving a diagnosis of this syndrome is associated with significant psychological distress, reduced well-being, depression, and fears about future health and fertility. […] Given the continued debate over criteria, and the often inadequate clinical care using the current framework for diagnosis of PCOS, it begs the question: after almost 20 years, is it time to revisit this diagnosis?

• #74 Polycystic Ovary Syndrome Diagnosis: The Promise of Artificial Intelligence for Improved Clinical Accuracy – Biomedical and Pharmacology Journal

  https://biomedpharmajournal.org/vol18no1/polycystic-ovary-syndrome-diagnosis-the-promise-of-artificial-intelligence-for-improved-clinical-accuracy/

  AI has a very high potential for diagnosing PCOS because of its heterogeneous nature, as well as its incorporation of clinical, biochemical, and radiological features. […] AI-driven tools enter the scenario: for both early detection and ongoing management of PCOS. […] These AI techniques can integrate clinical, biochemical, and imaging data toward a better understanding of the variability in PCOS, thereby possibly identifying signs that would be undetected otherwise. […] The integration of clinical and imaging data also increases the accuracy of diagnosis. […] The combination of models, such as an ensemble, has outstanding accuracy of 98.87% with LR, RF, DT, NB, SVM, KNN, XGBoost, AdaBoost classifiers. […] The combination of models, such as an ensemble, has outstanding accuracy of 98.87% with LR, RF, DT, NB, SVM, KNN, XGBoost, AdaBoost classifiers.

• #75 Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) – practice guidance | American Society for Reproductive Medicine | ASRM

  https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

  Anti-obesity agents and bariatric/ metabolic surgery may be considered based on general population guidelines, balancing potential for benefits and side effects. […] Letrozole is the preferred first line pharmacological infertility therapy, with clomiphene in combination with metformin; gonadotrophins or ovarian surgery primarily having a role as second line therapy. […] In vitro fertilization (IVF) could be offered, potentially with in vitro maturation, as third line therapy, where other ovulation induction therapies have failed and in the absence of an absolute indication for IVF in women with PCOS and anovulatory infertility. […] Given the underlying risk for pregnancy complications in PCOS, single embryo transfer should be preferred. […] Overall, evidence in PCOS is low to moderate quality. […] Based on high prevalence and significant health impact, greater priority, education, models of care, funding, and research are recommended.

Zobacz więcej